|
|
|
|
|
| Lübeck - Sales of the Dräger Group, a leading supplier of medical, safety and aerospace technology, grew by around 15 percent to DM 850 million in the first half of 2000 (up from DM 750 million), allowing Dräger to build upon its good market position in all the major markets, i.e. in Germany, Western Europe, USA and South-East Asia. The operating result is slightly up on the previous year's. |
|
| As Board Chairman Theo Dräger already announced at the General Shareholders' Meeting in Lübeck at the end of June, the company intends over the next few months to closely scrutinize its cost structure and business processes in view of continuing pressure on prices in the global markets. More detailed information regarding the scale of this cost reduction programme, possible job cuts and the resulting impact on net profit will not be available until September at the earliest, once proposals from the individual business units have been sub-mitted to Group management.
|
|
| In addition, it was announced that Dräger Medical Technology in Lübeck is preparing the launch of two interesting new products for the areas of neonatology and intensive care medicine, that Dräger Safety Technology has taken over the Swedish disposable filters manufacturer ACE (Svenljunga) and that Dräger Aerospace GmbH, Lübeck, has entered into a cooperation agreement with the American manufacturer Carleton Technologies (Buffalo / USA) to boost its activities in the area of aircraft oxygen supply systems. Thus the Dräger Group is adding to the strengths and competencies of its product portfolio. |
|
|
|
|
|
|
|
|
|
(c) Drägerwerk AG & Co. KGaA, 2007 |
|
 |
|
|
|
|
|
 |
|
